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ABSTRACT 
Capsaicin is a pungent ingredient in chili red peppers and has been linked to 
suppression of growth in various cancer cells. However, the underlying mechanism(s) 
by which capsaicin induces growth arrest and apoptosis of cancer cells is not 
completely understood. In the present study, we investigated whether capsaicin alters 
β-catenin-dependent signaling in human colorectal cancer cells in vitro. Exposure of 
SW480, LoVo, and HCT-116 cells to capsaicin suppressed cell proliferation. Transient 
transfection with a β-catenin/T-cell factor (TCF)-responsive reporter indicated that 
capsaicin suppressed the transcriptional activity of β-catenin/TCF. Capsaicin treatment 
resulted in a decrease of intracellular β-catenin levels and a reduction of transcripts 
from the β-catenin gene (CTNNB1). These results were confirmed by a reduced 
luciferase reporter activity driven by promoter-reporter construct containing the promoter 
region of the Catnb gene. In addition, capsaicin destabilized β-catenin through 
enhancement of proteosomal-dependent degradation. Western blot and 
immunoprecipitation studies indicated that capsaicin treatment suppressed TCF-4 
expression and disrupted the interaction of TCF-4 and β-catenin. This study identifies a 
role for the β-catenin/TCF-dependent pathway that potentially contributes to the anti-
cancer activity of capsaicin in human colorectal cancer cells.    3 
1. INTRODUCTION 
Colorectal cancer is an important public health problem in the Western world and 
the third leading cause of cancer-related death in the United States [1]. A total of 
142,570 new colorectal cancer cases and 51,370 colon cancer-related deaths are 
expected in the United States in 2010 [2].  
A number of case-control and cohort studies have demonstrated an inverse 
relationship between the consumption of vegetables and colorectal cancer [3]. Among 
common vegetables selected on the basis of consumption per capita data in the United 
States, red chili pepper showed very high anti-proliferative and anti-oxidant activity [4], 
and Americans' consumption of chili peppers has doubled to almost 6 pounds per capita 
per year since 1980 [5].  
Capsaicin is a major ingredient in hot chili pepper, and recent studies demonstrated 
anti-cancer activities of capsaicin in various types of cancer models [6-13]. However, 
capsaicin also acts as a co-carcinogen or tumor promoter in some cancer models, 
including skin [14] and stomach [15]. Previously, we and others reported that capsaicin 
inhibits growth of colorectal cancer and tumor formation [6, 7, 16-19], and capsaicin-
induced apoptosis is mediated by various mechanisms including AMPK, caspase-3, 
PPAR, ROS, p53, TRPV6, EGFR/HER-2 and E2F [7-13, 18-22].  
A high incidence of human colorectal cancer has been associated with genetic 
alteration of either the β-catenin gene (CTNNB1) or the adenomatous polyposis coli 
(APC) gene, the products of which interact with casein kinase 1ʱ, glycogen
 synthase 
kinase-3β (GSK-3β), and axin [23]. In the absence of Wnt stimulation, β-catenin is 
destabilized by phosphorylation and subsequent proteasomal degradation through   4 
active GSK-3β. Free β-catenin accumulates in the cytoplasm and translocates into the 
nucleus, where it binds to the members of the T-cell factor (TCF) / lymphoid enhancer 
factor (LEF) family and transactivates several target genes, including cyclin D1 [24], c-
myc [25], and PPAR-ʴ [26]. In particular, the formation of the β-catenin/TCF-4 complex 
results in a master switch that controls proliferation in malignant intestinal epithelial cells 
[27]. Therefore -catenin signaling is a significant target of chemoprevention by dietary 
compounds [28-30]. 
The current study was performed to elucidate the mechanism by which capsaicin 
might prevent the growth of human colorectal cancer cells. Here, we report that 
capsaicin suppresses -catenin/TCF-dependent pathways through multiple 
mechanisms, including suppression of β-catenin transcription, activation of proteosomal 
degradation of β-catenin, and disruption of β-catenin/TCF-4 interactions in human 
colorectal cancer cells.    5 
2. MATERIALS AND METHODS 
2.1. Materials  
Capsaicin was purchased from BIOMOL (Plymouth Meeting, PA) and dissolved in 
absolute ethanol. Polyclonal antibody for β-catenin (#9562) and monoclonal antibody for 
TCF-4 (#2953) were purchased from Cell Signaling (Beverly, MA). Antibodies for cyclin 
D1 (sc-718), C/EBPα (sc-9315), ubiquitin (sc-8017) and actin (sc-1615) were purchased 
from Santa Cruz (Santa Cruz, CA). Antibody for GFP (130-091-833) was obtained from 
Miltenyi Biotec (Auburn, CA). MG-132, puromycin and cycloheximide were purchased 
from Calbiochem (San Diego, CA). The GFP-β-catenin expression vector, TOP/FOP 
FLASH luciferase constructs and cyclin D1 promoter were described previously [31, 32]. 
Cell culture media were purchased from Invitrogen (Carlsbad, CA). All chemicals were 
purchased from Fisher Scientific, unless otherwise specified. 
2.2. Cell culture and treatment  
Human colorectal carcinoma cells (SW480, LoVo, and HCT-116) were purchased 
from American Type Culture Collection (Manassas, VA) and were grown at 37°C under 
a humidified atmosphere of 5% CO2. SW480, LoVo and HCT-116 cells were maintained 
in RPMI1640, Ham’s F-12 and McCoy 5A media, respectively. All media were 
supplemented with 10% fetal bovine serum (FBS) and a mixture of penicillin (100 U/mL) 
and streptomycin (100 µg/mL). The cells were grown in 12-well plates (for luciferase 
analysis of TOP/FOP reporter gene, β-catenin or cyclin D1 promoter), 6-well plates (for 
overexpression of GFP-β-catenin) or 10 cm plates (for immunoprecipitation) at a 
concentration of 2x10
5 cells/mL and then treated with capsaicin at concentrations or 
time points indicated in figure legends.    6 
2.3. Analysis of cell proliferation and cell viability  
Cell proliferation assay was performed using the Cell Proliferation Assay system 
(Promega, Madison, WI). Briefly, SW480 (3000 cells/well), LoVo (3000 cells/well) and 
HCT-116 (1000 cells/well) cells were plated in 96-well culture plates and incubated 
overnight. Next day, the cells were treated with 0, 50, or 100 µM of capsaicin in media 
containing 1% FBS for 0, 1, 2, or 3 d. The cells were incubated with CellTiter96 
Aqueous One solution (20 µL) for 1 h at 37°C and absorbance (A490) was recorded in an 
ELISA plate
 reader (Bio-Tek Instruments Inc, Winooski, VT). Cell viability was measured 
using Cell Titer-Glo Luminescent Cell Viability Assay system (Promega). SW480 cells 
were plated in 96-well culture plates and incubated with 0, 50, or 100 µM of capsaicin 
for 48 h. Then the cells were lysed by Cell Titer-Glo solution for 2 m with shaking and 
luminescence signal was stabilized for 10 m at room temperature. The luciferase activity 
was measured using a luminometer TD-20/20 (Turner Design, Sunnyvale, CA). 
2.4.Transient transfections  
Transient transfections were performed using the Lipofectamin 2000 (Invitrogen) or 
PolyJet DNA transfection reagent (SignaGen Laboratories, Ijamsville, MD) according to 
the manufacturer’s instruction. The cells were transiently transfected with expression 
vectors (GFP-β-catenin) or luciferase constructs (TOP/FOP Flash, β-catenin or cyclin 
D1 promoter) for 24 h. For luciferase assay, the cells were harvested in 1X luciferase 
lysis buffer, and luciferase activity was determined and normalized to the pRL-null 
luciferase activity using a dual luciferase assay system (Promega) as we described 
previously [16, 33].  
2.5. Western blotting    7 
After three washes with ice-cold PBS, cells were scraped into an eppendorf tube 
and lysed with radioimmunoprecipitation assay (RIPA) buffer containing a 
protease/phosphatase inhibitors cocktail (Pierce). After centrifugation at 10,000xg for 10 
min at 4°C, the supernatant was collected, and protein concentration was determined by 
the BCA protein assay (Pierce) using bovine serum albumin as a standard. The proteins 
were separated on SDS-PAGE and transferred to nitrocellulose membranes. The 
membranes were incubated with a specific primary antiserum in TBS containing 0.05% 
Tween 20 (TSB-T) and 5% nonfat dry milk at 4°C overnight. After four washes with 
TBS-T, the blots were incubated with horse radish peroxidase-conjugated IgG for 1 h at 
room temperature and visualized using ECL (Amersham Biosciences, Piscataway, NJ). 
2.6. Immunoprecipitation  
Cells were lysed using M-PER mammalian protein extraction reagent (Thermo 
Scientific, Rockford, IL) for 30 m and then centrifuged for 5 m at 10,000xg at 4°C. The 
supernatants were incubated with polyclonal anti- β-catenin antibody (1:100) overnight 
at 4°C, followed by incubation with protein A/G beads (Santa Cruz) for 2 h at 4°C. After 
washing four times in ice-cold PBS, the protein complex was boiled in an equal volume 
of 2X SDS-sample buffer and used for immunoblotting using monoclonal anti-ubiquitin 
or monoclonal anti-TCF-4 antibody.  
2.7. Preparation of nuclear extracts  
The cells were plated onto a 10 cm culture dish and treated with capsaicin. Nuclear 
extracts were harvested using the Nuclear Extract Kit (Active Motif, Carlsbad, CA), 
according to the manufacturers’ protocol.   
2.8. Isolation and analysis of RNA    8 
Total RNA was prepared using an RNA isolation kit (Eppendorf, Hamburg, 
Germany), according to the manufacturer’s instructions. One µg of total RNA was 
reverse-transcribed with an iScript cDNA kit (BioRad, Hercules, CA), according to the 
manufacturer’s instruction. PCR was carried out for 25 cycles at 94°C for 30 s, 55°C for 
30 s, and 72°C for 1 min using ReadyMix Taq polymerase (Sigma, St.Louis, MO) with 
human PCR primers as follows: β-catenin (CTNNB1): forward 5’-cccactaatgtccagcgttt-3’, 
and reverse 5’-aatccactggtgaaccaagc-3’, GAPDH: forward 5’-gggctgcttttaactctggt-3’, 
and reverse 5’-tggcaggtttttctagacgg-3’.   
2.9. Statistical analysis  
Statistical analysis was performed with the Student t test, with statistical 
significance set at *, P < 0.05; **, P < 0.01; ***, P < 0.001.   9 
3. RESULTS 
3.1. Inhibitory effects of capsaicin on growth of colorectal cancer cells 
To investigate whether capsaicin possessed anti-proliferative activity in APC mutant 
human colorectal cancer cells, SW480 and LoVo cells (APC mutant, β-catenin wild 
type) were exposed to 0, 50 and 100 µM of capsaicin for 0, 1, 2, or 3 d, and cell 
proliferation was performed as described in Materials and Methods. We also measured 
anti-proliferative activity of capsaicin in HCT-116 cells (APC wild type, β-catenin mutant). 
As shown in Fig. 1, growth of all three human colorectal cancer cell lines was inhibited 
by capsaicin treatment in a dose- and time-dependent manner.  Although 50 µM 
capsaicin treatment decreased cell growth to some extent, significantly retarded cell 
growth was observed in cells treated with 100 µM of capsaicin. In addition, these data 
indicated that cell growth arrest by capsaicin exposure was mediated in an APC-
independent manner.   
3.2. Decreased transcriptional activity of β-catenin by capsaicin treatment 
Alteration of β-catenin signaling caused by mutation in the APC or CTNNB1 gene is 
associated with colorectal tumorigenesis  [34]. In order to determine whether capsaicin 
modulated -catenin/TCF-dependent activity, a luciferase reporter assay was performed 
using TOP-FLASH or FOP-FLASH constructs containing six copies of wild type or 
mutated TCF binding sites, respectively. Capsaicin treatment significantly inhibited the 
TOP/FOP ratio in a dose-dependent manner, in cells treated with 50 and 100 µM of 
capsaicin for 48 h (Fig. 2).  These findings indicated that capsaicin suppressed β-
catenin/TCF-dependent signaling in human colorectal cancer cells.  
3.3. Decreased expression of β-catenin by capsaicin treatment   10 
Increased expression or nuclear translocation of β-catenin allows interaction with 
the TCF/LEF transcription factors and
 stimulates transcription of downstream β-catenin 
target genes. To test whether capsaicin affects expression of β-catenin, we performed 
Western blot in the colorectal cancer cells treated with 0, 50, or 100 µM capsaicin. As 
shown in Fig. 3A, capsaicin treatment resulted in the inhibition of β-catenin expression 
in SW480 cells, compared with untreated cells. In addition, incubation with 100 µM of 
capsaicin was associated with a significant decrease in β-catenin levels in LoVo cells 
(Fig. 3B). Interestingly, capsaicin treatment did not affect expression of β-catenin protein 
in HCT-116 cells (Fig. 3C). Time course experiments showed that β-catenin began to 
decrease at 24 h, and markedly decreased at 48 h in SW480 and LoVo cells, 
respectively (Fig. 3D, E). Expression of cyclin D1 decreased in the cells treated with 
capsaicin, but the decrease of cyclin D1 expression was much more pronounced than 
that of β-catenin in the cells, and occurred at an earlier time (12 h).  
It is also expected that nuclear translocation of β-catenin is positively associated 
with transcriptional activity of β-catenin. To define whether capsaicin alters nuclear 
localization, we performed Western blot from fractionated nuclear or cytosolic lysates 
after 48 h capsaicin treatment. The result shows that capsaicin treatment in SW480 
cells did not alter nuclear translocation of endogenous (Fig. 4A) and ectopically 
transfected β-catenin (Fig. 4C). Instead, capsaicin treatment decreased β-catenin 
protein level in both fractions (nucleus and cytosol). This trend was also observed in 
LoVo cells (Fig. 4B, D). Isolation of nuclear and cytosol proteins was validated by the 
expression of C/EBPʱ, which is expressed only in the nucleus. It is notable that 
ectopically expressed β-catenin was mainly localized in the cytosol fraction (Fig. 4C, D).   11 
The results indicated that capsaicin treatment simultaneously decreased the 
accumulation of β-catenin in the nucleus as well as in the cytosol. However, consistent 
with results of Fig. 3C, Western blot with endogenous or ectopically expressed GFP-
labeled β-catenin was not altered by capsaicin treatment in HCT-116 cells (data not 
shown).  
3.4. Transcriptional down-regulation of the β-catenin gene by capsaicin in SW480 cells 
To investigate the possible molecular mechanism of capsaicin in down-regulation of 
β-catenin, SW480 cells were incubated with 0, 50, or 100 µM of capsaicin, and mRNA 
levels of β-catenin were measured using RT-PCR. The result revealed a dose-
dependent decrease in transcript levels of β-catenin after capsaicin treatment (Fig. 5A). 
We also observed a significant decrease of cyclin D1 mRNA in the cells treated with 
100 µM of capsaicin (data not shown). To investigate whether a decrease of β-catenin 
mRNA is associated with transcriptional regulation of a gene encoding the β-catenin 
protein, mouse Catnb promoter (spanning -2153 to +18) was transfected into cells, and 
luciferase activity was measured after 48 h treatment of capsaicin. As shown in Fig. 5B, 
capsaicin treatment resulted in the suppression of promoter-reporter activity by 16% 
and 41% in the cells treated with 50 and 100 µM of capsaicin, respectively.  
Down-regulation of β-catenin inhibits interaction of β-catenin with the TCF/LEF 
family of transcription factors and deactivates transcription of downstream genes such 
as cyclin
 D1 [24]. Thus, to test whether capsaicin affects transcriptional activity of the 
cyclin D1 gene, we measured luciferase activities of cyclin D1 promoter containing -163 
and +130, which contains the TCF binding site [35]. Capsaicin treatment resulted in a 
dose-dependent decrease of cyclin D1 promoter activity, greater than that seen for   12 
Catnb (Fig. 5C). Together with results of Fig. 3(D, E), these data imply that down-
regulation of cyclin D1 transcription is independent of β-catenin down-regulation.  
We also compared cell viability to see whether decreased promoter activity is a 
result of cell death. As shown in Fig. 5D, cell viability decreased 9% and 17% in the 
cells treated with 50 and 100 µM of capsaicin, respectively. The decreased cell viability 
seems to be a result of activated apoptosis because we and others observed that 
capsaicin induces apoptosis in human colorectal cancer cells [7-13, 16, 18-22]. 
However, decreased rate of cell viability (9 and 17%) is much less than those of 
promoter activities of β-catenin (16 and 41%) or cyclin D1 promoter (32 and 74%), 
implying that decreased promoter activity represents transcriptional down-regulation of 
β-catenin and cyclin D1. 
3.5. Proteosomal degradation of β-catenin by capsaicin  
β-catenin becomes stabilized when proteasome-mediated proteolysis is inhibited, 
and this leads to the accumulation of multi-ubiquitinated forms of β-catenin [36]. Thus, 
we tested whether proteasomal degradation contributes to the decrease of β-catenin 
protein levels using the proteasome inhibitor MG-132. Pre-treatment with MG-132 
diminished capsaicin-mediated down-regulation of β-catenin in SW480 and LoVo cells 
(Fig. 6A, B). Next, to confirm this data, we compared β-catenin protein levels after 
capsaicin treatment in the presence of the protein synthesis inhibitor cycloheximide 
(CHX). GFP-tagged β-catenin expression vector was transfected into SW480 cells and 
the cells were co-treated with CHX and capsaicin for indicated times. As shown in Fig. 
6C, degradation of β-catenin occurred more rapidly in the presence of capsaicin. This 
more rapid degradation of β-catenin by capsaicin treatment was also observed in LoVo   13 
cells (data not shown). These results suggest that capsaicin suppresses β-catenin 
expression at both transcriptional and post-translational levels. 
It is well established that β-catenin is degraded by the 26S proteasome after the 
covalent binding with ubiquitin [23]. To confirm that the reductions in β-catenin levels by 
capsaicin treatment are indeed caused by this mechanism, we tested whether capsaicin 
treatment results in an increase of ubiquitinated β-catenin levels. The results show that 
appearance of an ubiquitin immunoreactive β-catenin band is increased by the addition 
of capsaicin (Fig. 6D and E). In reflecting decreased immunoprecipitated β-catenin in 
response to capsaicin, it seems likely that the β-catenin-conjugated ubiquitination was 
increased significantly by capsaicin treatment. As shown in Fig. 6E (right panel) 
normalizing amounts of immunoprecipitated β-catenin in immunoprecipitation step 
revealed a more dramatic increase in ubiquitinated bands on the immunoblots.  
3.6. Capsaicin decreased TCF-4 expression and binding of β-catenin to TCF-4 
Another possible mechanism regulating transcriptional activity of β-catenin is 
integrity of the β-catenin/TCF complex, which is required for normal transcriptional 
activity. Because cellular levels of β-catenin protein expression remained unchanged in 
HCT-116 cells (Fig. 3C), despite suppressed transcriptional activity of β-catenin (Fig. 
2C), we examined the possibility that capsaicin disrupts the association of β-catenin 
with TCF-4. For this, cell lysates were pulled down with β-catenin and immunoblotted 
with anti-TCF-4 antibody. As a result, a substantial level of β-catenin is associated with 
TCF-4 in vehicle-treated cells: however, capsaicin treatment abolished the association 
between β-catenin and TCF-4 in all three human colorectal cancer cells (Fig. 7A, B, C).     14 
We also sought to determine the changes of TCF-4 expression after capsaicin 
treatment. As shown in Fig. 7(D, E, F), TCF4 expression was decreased by capsaicin 
treatment in human colorectal cancer cells. This result indicates that the capsaicin-
mediated decrease of TCF-4 expression blocks the β-catenin-TCF4 interaction.  
   15 
4. DISCUSSION 
Hot chili red peppers are among the most heavily and frequently consumed spices. 
Capsaicin found in these peppers has been subjected to extensive experimental and 
clinical investigations due to its prominent pharmacologic and toxicological properties 
[37]. In a previous study, we observed that capsaicin treatment significantly induced 
growth arrest and apoptosis of human colorectal cancer cells [16]. However, the 
underlying mechanisms by which capsaicin affects human colorectal carcinoma have 
been only partially determined. 
Deregulation of β-catenin/TCF-dependent signaling is an important event in the 
development of various malignancies, including colorectal and other types of cancer. In 
most colorectal cancer cells, the β-catenin/TCF pathway is constitutively active at a high 
level due to defective APC or β-catenin genes and plays a crucial role in the 
progression of a subset of these cancers, suggesting an important target in the control 
of cellular proliferation or cell death. Therefore, we focused on β-catenin expression as 
an anti-proliferative target of capsaicin. For the first time, our data reveal that expression 
of β-catenin is suppressed by capsaicin treatment in APC mutant human colorectal 
cancer cells in which the β-catenin pathway is active. 
In this study, we observed that capsaicin down-regulates β-catenin transcription as 
well as protein stability. Simultaneous transcriptional and post-translational modulation 
of β-catenin has been reported previously by other research groups. Treatment with 
indomethacin or activation of cGMP-dependent protein kinase in human colorectal 
cancer cells suppressed β-catenin expression via transcriptional as well as post-
translational modification [38, 39]. Although marked increases in the levels of mRNA   16 
and promoter activity of the CTNNB1 gene were found in the carcinomas compared with 
the non-neoplastic mucosa [40-42], very little data looks at the regulation of β-catenin 
expression at the transcriptional level. In this report, we found that capsaicin reduced β-
catenin expression through down-regulation of β-catenin mRNA expression in SW480 
cells (Fig. 5). The promoter region of the gene encoding the -catenin protein contains 
binding sites for several important transcription factors, in human, rat, and mouse [43]. 
Protein/DNA array analyses identified several of these transcription factors for the rat 
Ctnnb1 promoter, including E2F1, NFkB, MEF1, Smad3/4, and GATA [43]. So, 
mechanistic studies for transcriptional down-regulation of the β-catenin gene by 
capsaicin are required in the future. β-catenin mRNA was decreased by 40% and 60% 
whereas promoter activity was decreased by 16% and 41% in 50 and 100 µM 
capsaicin-treated cells, respectively (Fig. 5A, B). The reason of discrepancy between 
mRNA and promoter activity is probably that capsaicin affects β-catenin mRNA stability 
or that the promoter used in this study may not contain all the necessary regulatory 
elements for β-catenin transcription.  
In addition to transcriptional down-regulation, we observed that capsaicin treatment 
enhanced β-catenin degradation, which is associated with increased ubiquitination of β-
catenin (Fig. 6). Since SW480 and LoVo cells contain a mutated APC gene that 
encodes for a truncated APC protein [44], it is likely that suppression of β-catenin by 
capsaicin is accomplished via APC-independent, proteasome-mediated pathways [38, 
45, 46].  
Interestingly, in HCT-116 cells (APC wild type, β-catenin mutant) we observed 
significant suppression of β-catenin transcriptional activity (Fig. 2C) without reduction of   17 
the β-catenin level (Fig. 3C) or alteration of β-catenin distribution between the nucleus 
and cytosol (data not shown) upon treatment with capsaicin. This rules out the 
possibility that the capsaicin interference with -catenin/TCF-dependent transcription is 
mediated by regulating the total amount of β-catenin and/or its cellular distribution. Thus, 
we tested the possibility that other molecules associated with regulation of β-catenin 
transcriptional activity may be altered under the influence of capsaicin. As a result, we 
observed that capsaicin suppressed TCF-4 expression and disrupted protein-protein 
interaction between β-catenin and TCF-4 in HCT-116 cells (Fig. 7). Thus, the possible 
explanation for discrepancy between impaired transcriptional activity and no alteration 
of β-catenin is that capsaicin directly inhibits TCF-4 expression and interferes with the 
formation of a transcriptionally active complex between β-catenin and TCF-4. Because 
TCF-4 has been shown to be constitutively activated by mutated β-catenin and 
induction of the pro-apoptotic pathway directly leads to the reduction of TCF-4 mRNA 
and protein levels [47], TCF-4 could be a therapeutic target for anti-cancer drugs. One 
aspect remaining unresolved in this study is the detailed mechanism of how capsaicin 
down regulates TCF-4 expression. This needs to be elucidated in a future study.  
We do not yet know the precise reason(s) as to why HCT-116 cells are resistant to 
a decrease of β-catenin protein in response to capsaicin treatment. One speculation 
could be that mutation of β-catenin in HCT-116 cells causes resistance of β-catenin 
degradation to capsaicin. It has been known that HCT-116 cells possess loss of 
conserved serine residue (Ser
45), which leads to activating mutations of β-catenin [44, 
48]. Because phosphorylation of β-catenin in Ser
45 residue by CK1 primes β-catenin for   18 
subsequent phosphorylation by GSK-3 [49], we speculate that deficiency of β-catenin 
phosphorylation at Ser
45 in HCT-116 cells causes resistance to β-catenin degradation. 
 The effect of capsaicin on β-catenin/TCF-dependent gene transcription
 can be 
important for capsaicin-induced anti-tumorigenesis. One established downstream target 
of -catenin/TCF transcription is cyclin D1, an important cell-cycle regulator. However, 
our results indicate that reduction in cyclin D1 protein levels is independent of 
downregulation of -catenin because loss of cyclin D1 protein occurred 12 h prior to the 
loss of -catenin in time-course studies (Fig 3D,E). In this study, we also observed that 
TCF-4 was decreased at 24 h after capsaicin treatment, earlier than β-catenin (Fig. 7D-
F) and transcriptional activity of β-catenin is suppressed in the cells treated with 100 µM 
of capsaicin for 24 h (data not shown). Taken together, these data indicate that the 
decrease of TCF-4 by capsaicin treatment is more likely responsible than β-catenin loss 
for suppression of transcriptional activity of β-catenin/TCF-driven gene expression such 
as cyclin D1. However, we do not exclude the possibility that reduction of cyclin D1 
could be a consequence of multiple mechanisms including proteasome degradation 
because cyclin D1 is a target of proteasomal degration by various compounds including 
6-gingerol [32], curcumin [50], retinoic acid [51], and troglitazone [52]. Although we did 
not compare cell cycles in this study, it has been reported that capsaicin results in 
sustained suppression of cyclin
 D1 levels and consequently the inhibition of G1 to S
 
transitions [10-12]. 
The concentration used in this study (100 µM) is equivalent to those used in several 
other studies using human colorectal cancer cells in vitro [7, 17, 18]. We do not know 
the exact physiological concentration of capsaicin and effective in vivo dose  to   19 
suppress colon cancer in humans. There is much concern that concentration used in in 
vitro are relevant in vivo. Thus, prediction of relevant in vitro doses should be 
considered with couples of factors including bioavailability, potential active metabolites 
and local concentration.  
Vanilloid receptor-1 (VR-1) is a well known receptor of capsaicin and mediates 
capsaicin’s biological roles including anti-cancer activity [53]. Capsaicin is also known to 
mediate apoptosis through a PPAR-dependent pathway [19], which also down-
regulates cyclin D1 expression [54]. Because we observed that human colorectal 
cancer cells express VR-1 and capsaicin is a ligand of PPARγ (data not shown), we 
tested whether capsaicin-mediated β-catenin suppression is mediated by these two 
pathways by treatment of cells with selective inhibitors against VR-1 (capsazepine;CPZ) 
or PPAR (GW9662). The result indicated that capsaicin down-regulates β-catenin and 
cyclin D1 via a VR-1- and PPAR-independent pathway (data not shown), consistent 
with other studies reporting no association between VR-1 or PPAR and capsaicin-
mediated carcinogenesis [14, 19, 55]. However, Kim et al. (2004) claimed that 
capsaicin-induced apoptotic cell death is mediated by the PPAR pathway in HT-29 
human colorectal cancer cells [19]. Discrepancy between PPAR-dependent apoptosis 
and independent β-catenin suppression is not clearly demonstrated, but it is likely due 
to differences of cell type and study context.  
In conclusion, we identified β-catenin/TCF-4 mediated transcription as a target of 
capsaicin. Capsaicin-mediated suppression of β-catenin transcriptional activity is 
associated with multiple mechanisms including transcriptional down-regulation of the β-
catenin gene and enhanced protein degradation in APC-mutant, β-catenin wild type   20 
human cancer cells and suppression of TCF4 in APC-wild type and β-catenin mutant 
human colorectal cancer cells. The current study will help to explain some features of 
capsaicin-mediated chemoprevention in human colorectal cancer.    21 
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LEGENDS FOR FIGURES 
Fig. 1. Inhibitory effect of capsaicin on proliferation of colorectal cancer cells. Human 
colorectal cancer cells SW480 (A), LoVo (B) and HCT-116 (C) were treated with 0, 50 
or 100 µM of capsaicin in 1% serum containing media for 0, 1, 2, and 3 days. Cell 
growth was measured using CellTiter96 Aqueous One Solution Cell Proliferation Assay 
and expressed as absorbance (A490). *, P<0.05; ***, P < 0.001 versus vehicle (ethanol)-
treated cells. 
 
Fig. 2. Decreased transcriptional activity of β-catenin by capsaicin treatment.  Human 
colorectal cancer cells SW480 (A), LoVo (B) and HCT-116 (C) were co-transfected with 
TOP-FLASH or FOP-FLASH constructs containing six copies of wild type or mutated 
TCF binding sites and pRL-null. Then, the cells were treated with 0, 50, and 100 μM of 
capsaicin for 48 h. Luciferase activity for TOP-FLASH and FOP-FLASH was measured 
as a ratio of firefly luciferase signal/renilla luciferase signal using a dual luciferase assay 
kit (Promega). A ratio of TOP-FLASH over FOP-FLASH was calculated and expressed 
as % inhibition over vehicle-treated cells. *, P<0.05; ** < 0.01; ***, P < 0.001 versus 
vehicle (ethanol)-treated cells. The data represent mean ± SD from three replicates. 
 
Fig. 3. Decreased expression of β-catenin by capsaicin treatment (A, B, C). Human 
colorectal cancer cells SW480 (A), LoVo (B) or HCT-116 (C) were treated with 0, 50 or 
100 µM of capsaicin for 24 or 48 h. (D, E) SW480 (D) or LoVo (E) cells were treated 
with 100 µM of capsaicin for indicated times. Cell lysates were harvested and subjected 
to SDS-PAGE. Western blot was performed using antibodies against β-catenin, cyclin 
D1, and actin. Data from three independent experiments were densitometrically   29 
analyzed using Scion Image (Scion Corporation, Frederick, MD) (lower panel). *, 
P<0.05 between 0 h and each time; #, P<0.05 between β-catenin and cyclin D1 at each 
time point. 
 
Fig. 4. Decreased expression of nuclear and cytosol β-catenin by capsaicin treatment. 
(A, B) SW480 cells (A) or LoVo cells (B) were plated onto 10 cm culture dish and then 
treated with capsaicin for 48 h. The nuclear and cytosol fractions were isolated and 
Western blot was performed against β-catenin, C/EBPα and actin antibodies.  (C, D) 
SW480 cells (C) or LoVo cells (D) were transfected with GFP-tagged β-catenin 
expression vector (GFP-β-catenin) and then treated with 100 µM of capsaicin for 48 h. 
Nuclear and cytosol fractions were isolated and Western blot was performed using GFP, 
C/EBPα and actin antibodies.  
 
Fig. 5. Transcriptional down-regulation of β-catenin by capsaicin. (A) SW480 cells were 
treated with 0, 50, and 100 µM of capsaicin for 48 h, and semi-quantatitive RTPCR was 
performed as described in Materials and Methods. Data from three independent 
experiments were densitometrically analyzed using Scion Image and β-catenin versus 
GAPDH was quantified and expressed as fold induction (Lower panel). **, P < 0.01 
versus vehicle-treated cells. (B) SW480 cells were transfected with β-catenin promoter 
and pRL-null, and then treated with 0, 50 and 100 µM of capsaicin for 48 h. Luciferase 
activity was determined and normalized to the pRL-null luciferase activity using a dual 
luciferase assay kit (Promega) and presented as % inhibition versus vehicle-treated 
group. *, P < 0.05; **, P < 0.01 versus vehicle-treated cells. The data represent mean ±   30 
SEM from three independent experiments. (C) SW480 cells were transfected with a 
reporter gene containing -163/+130 cyclin D1 promoter, and then the cells were treated 
with 0, 50 and 100 μM capsaicin for 48 h. Luciferase activity was measured as a ratio of 
firefly luciferase signal/renilla luciferase signal and is presented as % inhibition versus 
vehicle-treated group. ***, P < 0.001 versus vehicle-treated cells. (D) SW480 cells were 
treated with 0, 50, or 100 µM of capsaicin for 48 h and then cell viability was measured 
using Cell Titer-Glo Luminescent Cell Viability Assay system (Promega) as described in 
Materials and Methods. *, P < 0.05; **, P < 0.01 versus vehicle-treated cells. 
 
Fig. 6. Increased proteosomal degradation and ubiquitination of β-catenin by capsaicin. 
(A, B) SW480 cells (A) or LoVo cells (B) were pretreated with DMSO or MG-132 (10 
µM) for 30 min and then co-treated with ethanol or capsaicin for 48 h. Western analysis 
was performed for β-catenin and actin antibodies. (C) SW480 cells were transfected 
with GFP-tagged β-catenin expression vector. Then the cells were pretreated with 
vehicle (ethanol) or capsaicin for 1 h and then co-treated with 10 µg/mL of 
cycloheximide (CHX) for the indicated time points.  Western blot was performed for 
using antibodies against GFP and actin. (D, E) SW480 cells (D) or LoVo cells (E) were 
treated with 100 µM of capsaicin for 48 h, and then immunoprecipitation (IP) was 
performed by pull down of cellular protein with β-catenin antibody and subsequent 
immunoblotting with ubiquitin (Ub) antibody. Right panel indicates results after 
normalizing amounts of immunoprecipitated β-catenin in IP step. 
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Fig. 7. Decreased expression of TCF-4 by capsaicin treatment. (A, B, C) Human 
colorectal cancer cells SW480 (A), LoVo (B) and HCT-116 (C) were treated with 0 or 
100 µM of capsaicin for 48 h and then cellular protein was pulled down with β-catenin 
antibody and immunoblot was performed for TCF-4 antibody. (D, E, F) Human 
colorectal cancer cells SW480 (D), LoVo (E) and HCT-116 (F) were treated with 0, 50 or 
100 µM of capsaicin for 24 or 48 h. Cell lysates were harvested and subjected to SDS-
PAGE. Western blot was performed using antibodies against TCF-4 and actin.  
 
 